$CHE (Chemed Corp.)

$CHE {{ '2016-08-05T20:15:13+0000' | timeago}} • Announcement

$CHE, a provider of plumbing and drain services, said that its BoD declared a quarterly cash dividend of $0.26 per share on its capital stock. This dividend is payable on September 2, 2016, to shareholders of record as of August 15, 2016.

$HOLX {{ '2018-01-16T13:05:50+0000' | timeago}} • Announcement

$HOLX said its CE-marked Aptima HIV-1 Quant Dx assay has been awarded World Health Organization (WHO) prequalification for in vitro diagnostic. The Aptima HIV-1 Quant Dx assay is the first HIV-1 viral load assay with a dual claim for both diagnosis and treatment monitoring.

$HOLX {{ '2018-01-11T21:23:15+0000' | timeago}} • Announcement

Medical technology company $HOLX has elected Namal Nawana to its board of directors, effective immediately. Nawana was formerly the CEO of Alere, Inc. Prior to that, he served Johnson & Johnson in various leadership roles, including Worldwide President of DePuy Synthes Spine.

$HOLX {{ '2018-01-08T13:10:32+0000' | timeago}} • Announcement

Medical technology company $HOLX said it is currently looking for net revenues of about $791MM for the first quarter of 2018, higher than $775MM-$790MM the company had estimated earlier. The latest guidance represents an 8% YoY growth, reflecting the effect of divestiture of Hologic’s blood screening business and acquisition of Cynosure.

$HOLX {{ '2018-01-03T13:10:03+0000' | timeago}} • Announcement

$HOLX said the MyoSure MANUAL device, which was designed to simplify tissue removal procedures regardless of setting, has received CE mark in Europe. The MyoSure MANUAL device joins the MyoSure suite of gynecologic surgical products that offer simple and effective solutions to resect and remove tissue.

$ESRX {{ '2017-12-14T15:34:37+0000' | timeago}} • Announcement

$ESRX's enterprise value initiative is currently estimated to cost approx. $600-650MM and to deliver cumulative savings of nearly $1.2Bil by 2021. The company's 2018 full-year guidance includes an estimated contribution of $65-75MM in expense savings affecting the Core and consolidated businesses.

$ESRX {{ '2017-12-14T15:34:20+0000' | timeago}} • Announcement

For 2018, $ESRX expects adjusted diluted EPS to be $7.67-7.87, up 9-12% from the midpoint of the updated 2017 adjusted EPS guidance range. The company expects consolidated revenue to be $99-102Bil and Core revenue to be $80.5-83Bil. Total adjusted claims for the consolidated business is expected to be $1.34-1.39Bil.

$ESRX {{ '2017-12-14T15:34:05+0000' | timeago}} • Announcement

$ESRX expects full-year 2017 total adjusted claims for its Core business to be 1.15-1.17Bil, which is flat over Core 2016 total adjusted claims at the midpoint of the range. The company expects Core 2017 adjusted EBITDA guidance to be $4.91-4.97Bil, representing growth of 3% over Core 2016 adjusted EBITDA results at the midpoint of the range.

$ESRX {{ '2017-12-14T15:33:48+0000' | timeago}} • Announcement

$ESRX increased its consolidated 2017 adjusted EPS guidance range to $7.00-7.08, representing growth of 10% over 2016 adjusted EPS at the midpoint of the range. The company narrowed its consolidated 2017 adjusted EBITDA guidance from $7.35-7.47Bil to $7.37-7.45Bil, maintaining the midpoint of the range and up 2% over 2016.

$ABM {{ '2017-12-13T21:51:25+0000' | timeago}} • Announcement

$ABM said it expects to record GAAP earnings from continuing operations between $1.33 per share and $1.43 per share in fiscal 2018. Non-GAAP income from continuing operations is forecasted in the range of $1.70 per share to $1.80 per share.

$ABM {{ '2017-12-13T21:45:29+0000' | timeago}} • Announcement

Manufacturing firm $ABM slipped into the negative territory in 4Q17, hurt by higher expenses. The net loss was $0.06 per share, compared to earnings of $0.14 per share a year earlier. Revenues, meanwhile, rose 13% to $1.5Bil, mainly reflecting the acquisition of GCA Services Group. Organic revenue performance was driven mainly by new business wins.

$PMC {{ '2017-12-07T18:06:23+0000' | timeago}} • Announcement

$PMC announced the completion of the acquisition of PharMerica by a newly formed company controlled by KKR with an affiliate of $WBA as a minority investor.

$CVS {{ '2017-12-04T21:29:13+0000' | timeago}} • Announcement

$CVS has agreed to acquire $AET for appox. $207 per share or approx. $69Bil. Including the assumption of $AET debt, the total value of the deal is $77Bil. The transaction is expected to close in the second half of 2018.

$LHCG {{ '2017-12-04T19:56:36+0000' | timeago}} • Announcement

$LHCG and Erlanger Health System have finalized a new JV to enhance home health and community-based services in Chattanooga and southeast Tennessee. The JV includes a Chattanooga facility, which will operate as Erlanger ContinuCare Home Health. $LHCG expects annualized revenue from this JV of approx. $7MM and no material effect to 2017 diluted EPS.

$ESRX {{ '2017-11-27T17:11:32+0000' | timeago}} • Announcement

$ESRX said private equity firm Avista Capital Partners has signed a definitive agreement to acquire United BioSource (UBC), a wholly-owned subsidiary of $ESRX. UBC is a provider of pharmaceutical and patient support services, with 13 locations in the US, Europe, and Canada.

$HOLX {{ '2017-11-27T12:28:43+0000' | timeago}} • Announcement

Medical technology company $HOLX has signed a development and distribution agreement with Clarius Mobile Health, a manufacturer of ultrasound scanners, for supply of handheld wireless scanners. The devices will be used for early detection of breast cancer. The company did not disclose the financial terms of the agreement.

$LHCG {{ '2017-11-16T14:14:41+0000' | timeago}} • Announcement

$LHCG-$AFAM merger will create a nationwide provider of in-home healthcare services. The combined company will have 781 locations in 36 states with more than 31,000 employees and revenue of $1.8Bil and adjusted EBITDA of approx. $145MM for the trailing 12-month period ended Sept. 30, 2017.

$LHCG {{ '2017-11-16T14:13:01+0000' | timeago}} • Announcement

$LHCG and $AFAM have agreed to combine in an all-stock merger of equals transaction. Almost Family shareholders will receive 0.9150 shares of LHC Group for each existing Almost Family share. Upon closing of the transaction, LHC Group shareholders will own 58.5% and Almost Family shareholders will own 41.5% of the combined company.

$HOLX {{ '2017-11-09T15:40:48+0000' | timeago}} • Announcement

For FY18, $HOLX expects revenue to be $3.20-3.28Bil, GAAP EPS to be $1.22-1.27 and non-GAAP EPS is estimated to be $2.10-2.15. For 1Q18, revenue is estimated to be $775-790MM, GAAP EPS to be $0.25-0.27 and non-GAAP EPS is targeted $0.48-0.50.

$HOLX {{ '2017-11-09T15:34:46+0000' | timeago}} • Announcement

$HOLX's profit dropped 10% in its final quarter of FY17 despite a 11% increase in the revenue. Net income was $83MM or $0.29 per share on revenues of $803MM. On a non-GAAP basis, Hologic earned $0.50 per share.

$HOLX {{ '2017-11-08T22:16:36+0000' | timeago}} • Infographic

$HOLX Hologic, Inc. Earnings AlphaGraphic: Q4 2017 Highlights

Recent Transcripts

RAD (Rite Aid Corporation)
Wednesday, January 3 2018 - 10:00pm
ABM (ABM Industries Incorporated)
Thursday, December 14 2017 - 1:30pm
SPB (Spectrum Brands Holdings, Inc.)
Thursday, November 16 2017 - 2:00pm
ONVO (Organovo Holdings, Inc.)
Thursday, November 9 2017 - 10:00pm
TRXC (TransEnterix, Inc.)
Thursday, November 9 2017 - 9:30pm
HOLX (Hologic Inc.)
Wednesday, November 8 2017 - 9:30pm
PRSC (Providence Service Corp.)
Wednesday, November 8 2017 - 1:00pm
LHCG (LHC Group, Inc.)
Monday, November 6 2017 - 4:00pm
CVS (CVS Health Corporation)
Monday, November 6 2017 - 1:30pm
TXMD (TherapeuticsMD, Inc.)
Monday, November 6 2017 - 1:00pm
USPH (US Physical Therapy Inc.)
Thursday, November 2 2017 - 2:30pm
BIOS (BioScrip, Inc.)
Thursday, November 2 2017 - 1:00pm
SYN (Synthetic Biologics Inc.)
Wednesday, November 1 2017 - 8:30pm
STE (Steris Plc)
Wednesday, November 1 2017 - 2:00pm
CHE (Chemed Corp.)
Friday, October 27 2017 - 2:00pm
TVTY (Tivity Health, Inc.)
Thursday, October 26 2017 - 9:00pm
ESRX (Express Scripts Holding Company)
Wednesday, October 25 2017 - 12:30pm
PETS (PetMed Express, Inc.)
Monday, October 23 2017 - 12:30pm
ISRG (Intuitive Surgical, Inc.)
Thursday, October 19 2017 - 8:30pm
RAD (Rite Aid Corporation)
Thursday, September 28 2017 - 12:30pm

AlphaGraphics you may like